Legitimacy vs. Sensationalism: The Spectrum of Cannabis News Reporting

Recently we discussed the current status of cannabis research following the Federal Health Agency’s indictment of the plant’s Schedule I status as the cause of what the FHA deems ‘slow’ progress in this area. In fact, the number of small studies being published and making headlines in major publications is actually growing quite rapidly as more states legalize cannabis use.

Read More
Federal Health Agency Blames Schedule I Status For ‘Slow’ Cannabis Research, Commits To Fund Studies

Unfortunately, cannabis’ status as a Schedule I drug has delayed the progress of effective research about the plant’s medicinal uses. While some states have chosen to legalize cannabis at the state level, the DEA and the United States at large still categorize it as Schedule I controlled substance.

Read More